نتایج جستجو برای: tyr3

تعداد نتایج: 264  

2001
S. W. J. LAMBERTS

Recently, we developed a technique that allows the in uiuo visualization in man of somatostatin receptor-positive neuroendocrine tumors after iv injection of [iZ31-Tyr3]octreotide or [“‘In-DTPA-nPhe’loctreotide. Radiotherapy of such tumors using somatostatin analogs coupled to OLor P-emitting radionuclides has been proposed as an application for radiolabeled somatostatin analogs. To develop thi...

2016
Ho Sze Chan Mark W. Konijnenberg Erik de Blois Stuart Koelewijn Richard P. Baum Alfred Morgenstern Frank Bruchertseifer Wouter A. Breeman Marion de Jong

BACKGROUND Targeted alpha therapy has been postulated to have great potential for the treatment of small clusters of tumour cells as well as small metastases. (213)Bismuth, an α-emitter with a half-life of 46 min, has shown to be effective in preclinical as well as in clinical applications. In this study, we evaluated whether (213)Bi-[DOTA(0), Tyr(3)]-octreotate ((213)Bi-DOTATATE), a (213)Bi-la...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011
Julius Leyton Lisa Iddon Meg Perumal Bard Indrevoll Matthias Glaser Edward Robins Andrew J T George Alan Cuthbertson Sajinder K Luthra Eric O Aboagye

UNLABELLED The incidence and prevalence of gastroenteropancreatic neuroendocrine tumors has been increasing over the past 3 decades. Because of high densities of somatostatin receptors (sstr)--mainly sstr-2--on the cell surface of these tumors, (111)In-diethylenetriaminepentaacetic acid-octreotide scintigraphy has become an important part of clinical management. (18)F-radiolabeled analogs with ...

Journal: :Dalton transactions 2014
Brett M Paterson Peter Roselt Delphine Denoyer Carleen Cullinane David Binns Wayne Noonan Charmaine M Jeffery Roger I Price Jonathan M White Rodney J Hicks Paul S Donnelly

The use of copper radioisotopes in cancer diagnosis and radionuclide therapy is possible using chelators that are capable of binding Cu(II) with sufficient stability in vivo to provide high tumour-to-background contrast. Here we report the design and synthesis of a new bifunctional chelator, 5-(8-methyl-3,6,10,13,16,19-hexaaza-bicyclo[6.6.6]icosan-1-ylamino)-5-oxopentanoic acid (MeCOSar), that ...

Journal: :Endocrine-related cancer 2017
Tessa Brabander Wouter A van der Zwan Jaap J M Teunissen Boen L R Kam Wouter W de Herder Richard A Feelders Eric P Krenning Dik J Kwekkeboom

Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]octreotate (177Lu-DOTATATE) is a treatment with good results in patients with metastatic gastroenteropancreatic neuroendocrine tumours (GEPNETs). However, there are some pitfalls that should be taken into consideration when evaluating the treatment response after PRRT. 354 Dutch patients with GEPNETs who were treated with 177Lu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید